课题基金 / 基金详情

DIDEOXYNUCLEOSIDES AS POTENTIAL ANTI-AIDS DRUGS

DIDEOXYNUCLEOSIDES AS POTENTIAL ANTI-AIDS DRUGS
双脱氧核苷作为潜在的抗艾滋病药物
批准号:
3916557
负责人:
V E MARQUEZ
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:

项目摘要

项目成果

V E MARQUEZ的其他基金

相似基金

相关文献

中文摘要
翻译
5-溴和5-氟-2',3'-二脱氧胞苷被发现是
英文摘要
5-Bromo and 5-fluoro-2',3'-dideoxycytidine have been found to be active in the DTP anti-HIV screening program at FCRF. 2'-Fluoro-2',3'-dideoxyarabinosyl adenine is not only as active and potent as ddA in anti-HIV tests, it is completely stable to the acid catalyzed glycosidic cleavage which occurs so rapidly with ddA. Oral studies in the dog showed 83% bioavailability for the fluoro analogue but only 30% for ddA. Two five-member ring analogues of the fermentation product, oxetanocin, were prepared. The first had no cellular protective properties. The second is under evaluation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ENZYME INHIBITORS AS PROTENTIAL ANTICANCER AND ANTIVIRAL DRUGS
  • 批准号:
    5201243
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    --
  • 负责人:
    V E MARQUEZ
  • 依托单位:
DIDEOXYNUCLEOSIDES AS POTENTIAL ANTI-AIDS DRUGS
  • 批准号:
    5201241
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    --
  • 负责人:
    V E MARQUEZ
  • 依托单位:
CYCLOPENTENYL NUCLEOSIDE ISOSTERES AS POTENTIAL ANTITUMOR AND ANTIVIRAL AGENTS
  • 批准号:
    5201242
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    --
  • 负责人:
    V E MARQUEZ
  • 依托单位:
DIDEOXYNUCLEOSIDES AS POTENTIAL ANTI-AIDS DRUGS
国内基金
海外基金
基于病人旅程地图的HIV/AIDS患者双轨调适策略的混合性研究
基于潜变量增长混合模型的HIV/AIDS患者症状负担发展轨迹研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    胡亚丽
  • 依托单位:
基于RET理论模型下的曼陀罗彩绘疗法在老年HIV/AIDS患者中的心理干预研究
IL-33/NF-κB通路在臭氧暴露致HIV/AIDS患者免疫损伤中的调控机制研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位: